Nicola Marchi

Consequences of repeated blood-brain barrier disruption in football players.

Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.

Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.

Blood-brain barrier damage induces release of alpha2-macroglobulin.

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.

Endocannabinoid signalling in the blood of patients with schizophrenia.

Peripheral markers of brain damage and blood-brain barrier dysfunction.

Peripheral markers of blood-brain barrier damage.

Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring?

Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats.

Significance of MDR1 and multiple drug resistance in refractory human epileptic brain.

S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.

A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.

In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: insights into the mechanisms of pharmacoresistance.

Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.

Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development.

Seizure-promoting effect of blood-brain barrier disruption.

Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.

In vivo and in vitro effects of pilocarpine: relevance to ictogenesis.

ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.

Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release.

Antagonism of peripheral inflammation reduces the severity of status epilepticus.

Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema.

Small vessel ischemic disease of the brain and brain metastases in lung cancer patients.

Management of the patient with medically refractory epilepsy.

Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow.

Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.

Serum S100B: a potential biomarker for suicidality in adolescents?

Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity.

A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system.

Cellular localization and functional significance of CYP3A4 in the human epileptic brain.

Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics.

The etiological role of blood-brain barrier dysfunction in seizure disorders.

Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.

The role of shear stress in Blood-Brain Barrier endothelial physiology.

Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures.

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

The blood-brain barrier hypothesis in drug resistant epilepsy.

A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.

Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches.

Cerebrovascular remodeling and epilepsy.

Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains.

A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches.

Inflammatory pathways of seizure disorders.

Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits.

Is peripheral immunity regulated by blood-brain barrier permeability changes?

Redistribution of PDGFRβ cells and NG2DsRed pericytes at the cerebrovasculature after status epilepticus.

SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.

Status epilepticus: impact of therapeutic coma on outcome.

Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.

Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy.

Cerebrovascular pathology during the progression of experimental Alzheimer's disease.

Evidence for Status Epilepticus and Pro-Inflammatory Changes after Intranasal Kainic Acid Administration in Mice.

Lack of CAR impacts neuronal function and cerebrovascular integrity in vivo.

Pathophysiological implications of neurovascular P450 in brain disorders.

Callosal disconnection syndrome after ischemic stroke of the corpus callosum due to meningococcal meningitis: A case report.

Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.